Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2Kb and H-2Db-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma
- 1 April 2016
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 228, 26-37
Abstract
No abstract availableKeywords
Funding Information
- National Basic Research Program of China (2012CB932501)
- Nature Science Fund of China (81373360)
- Doctoral Fund of Ministry of Education of China (20120142120093)
- Fundamental Research Funds for the Central Universities (2014TS091, 2015YGYL024)
This publication has 44 references indexed in Scilit:
- Cancer Immunotherapy2013
- Dendritic-Cell-Based Therapeutic Cancer VaccinesImmunity, 2013
- Cancer immunotherapy comes of ageNature, 2011
- Multipeptide vaccination in cancer patientsExpert Opinion on Biological Therapy, 2009
- Novel multi‐peptide vaccination in Hla‐A2+ hormone sensitive patients with biochemical relapse of prostate cancerThe Prostate, 2009
- Targeting the innate immune response with improved vaccine adjuvantsNature Medicine, 2005
- Identification of Multiple Antigens Recognized by Tumor-Infiltrating Lymphocytes From a Single Patient: Tumor Escape by Antigen Loss and Loss of MHC ExpressionJournal of Immunotherapy, 2004
- MHC class I antigens, immune surveillance, and tumor immune escapeJournal of Cellular Physiology, 2003
- Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants.Journal of General Virology, 1998
- A synthetic peptide-based polyoxime vaccine construct of high purity and activityMolecular Immunology, 1995